Krsnaa Diagnostics shares surge 11% on Punjab PET-CT deal

Krsnaa Diagnostics shares surged 11% following the company's announcement of a significant infrastructure contract in the diagnostic imaging sector. According to reports, the company signed a 15-year concession agreement with Punjab Health Systems Corporation to establish its presence in PET-CT diagnostics. The pact involves developing and operating PET-CT facilities across four government hospitals in Punjab under a public-private partnership framework, marking the company's entry into this specialized imaging segment.

The contract represents a meaningful expansion of Krsnaa Diagnostics' service portfolio beyond its existing diagnostic capabilities. By partnering with a state health authority, the company gains access to government infrastructure while positioning itself to serve a broader patient population through publicly funded healthcare facilities. Long-term concession agreements in healthcare infrastructure typically provide revenue visibility and operational stability, factors that investors view favorably when assessing growth potential.

For traders monitoring India's healthcare services sector, such infrastructure partnerships underscore the ongoing shift toward privatization and efficiency improvements in public health systems. Government-backed diagnostic contracts offer predictable revenue streams and reduced commercial risk, particularly attractive in the post-pandemic period as states prioritize advanced diagnostic capabilities. The 11% share price response suggests positive market sentiment toward Krsnaa's strategic diversification and capacity expansion, while the extended contract duration indicates confidence in demand for advanced imaging services across India's healthcare ecosystem.

Source: Markets-Economic Times